AGING CONDITIONS: CANCER
Cancer in Women
Introduction
WHO [World Health Organisation]
recently classed combined oestrogen / progesterone oral
contraceptives as Group 1 carginagenics.
100 million women world wide use this drug. Dr Sam
Epstein, world leader in cancer prevention claims the
pill is the largest drug trial ever carried out, however,
the pill has been the most researched drug ever.
Claims are made that the 'pill' has both beneficial
and adverse affects:
- Increases breast, cervical and
liver cancer
- Decreases ovarian and endometrial
cancer
Claims
Dr Charlotte Paul of Otago University claims that of
women in their 20's using the pill over the next 10
years, 17 will get breast cancer, compared to 16 of
those not using it. 10 years after stopping, there is
no increase in risk. Its fine to take it at this age.
International agency on research in cancer previously
said the pill caused rare liver cancer, but now added
breast and cervical cancer. Cervical cancer screening
is a strong preventative measure.
Other risks of the pill are more important: venous
thrombosis leading to higher risk of heart attack or
stroke.
Longer Duration of Use
Women in their 40s, particularly those who are smokers
have a higher underlying risk of cancer, heart attacks
and strokes
Overall Risk
Overall, the Risk:Benefit analysis shows that the risks
do not outweigh the benefits.
|
